SAPONARO, FEDERICA
 Distribuzione geografica
Continente #
NA - Nord America 3.907
AS - Asia 1.934
EU - Europa 1.858
SA - Sud America 398
AF - Africa 208
OC - Oceania 6
Continente sconosciuto - Info sul continente non disponibili 2
Totale 8.313
Nazione #
US - Stati Uniti d'America 3.814
IT - Italia 680
CN - Cina 577
SG - Singapore 547
HK - Hong Kong 408
SE - Svezia 350
BR - Brasile 343
DE - Germania 194
AT - Austria 154
BG - Bulgaria 137
VN - Vietnam 128
GB - Regno Unito 87
CI - Costa d'Avorio 81
TR - Turchia 64
IN - India 59
RU - Federazione Russa 58
CA - Canada 51
FR - Francia 51
FI - Finlandia 35
MA - Marocco 32
SN - Senegal 27
NG - Nigeria 22
AR - Argentina 21
JP - Giappone 21
NL - Olanda 19
BD - Bangladesh 18
MX - Messico 18
KR - Corea 17
UA - Ucraina 16
IQ - Iraq 15
ZA - Sudafrica 15
UZ - Uzbekistan 14
BE - Belgio 12
EG - Egitto 12
PL - Polonia 12
CZ - Repubblica Ceca 10
SA - Arabia Saudita 10
EC - Ecuador 9
ID - Indonesia 9
KZ - Kazakistan 7
PY - Paraguay 7
RO - Romania 7
VE - Venezuela 7
KE - Kenya 6
PK - Pakistan 6
DK - Danimarca 5
ES - Italia 5
GR - Grecia 5
JM - Giamaica 5
AE - Emirati Arabi Uniti 4
AU - Australia 4
CO - Colombia 4
CR - Costa Rica 4
IE - Irlanda 4
AL - Albania 3
BB - Barbados 3
DZ - Algeria 3
HN - Honduras 3
MV - Maldive 3
TN - Tunisia 3
TT - Trinidad e Tobago 3
UY - Uruguay 3
AZ - Azerbaigian 2
CH - Svizzera 2
CY - Cipro 2
DO - Repubblica Dominicana 2
ET - Etiopia 2
EU - Europa 2
GT - Guatemala 2
IL - Israele 2
IR - Iran 2
JO - Giordania 2
KG - Kirghizistan 2
LB - Libano 2
LT - Lituania 2
NP - Nepal 2
NZ - Nuova Zelanda 2
PH - Filippine 2
PS - Palestinian Territory 2
PT - Portogallo 2
RS - Serbia 2
TW - Taiwan 2
ZM - Zambia 2
AO - Angola 1
BN - Brunei Darussalam 1
BO - Bolivia 1
BS - Bahamas 1
BY - Bielorussia 1
CG - Congo 1
CL - Cile 1
GA - Gabon 1
KW - Kuwait 1
LK - Sri Lanka 1
LU - Lussemburgo 1
LV - Lettonia 1
MD - Moldavia 1
MK - Macedonia 1
MY - Malesia 1
NI - Nicaragua 1
PE - Perù 1
Totale 8.310
Città #
Ashburn 474
Dallas 459
Hong Kong 404
Fairfield 304
Santa Clara 296
Singapore 271
Woodbridge 259
Chandler 248
Beijing 170
Houston 162
Shanghai 149
Milan 144
Serra 143
Ann Arbor 137
Sofia 137
Seattle 135
Vienna 134
Wilmington 122
New York 104
Cambridge 92
Abidjan 81
Los Angeles 80
Boardman 71
Princeton 71
Munich 69
Florence 68
Pisa 67
Lawrence 58
Medford 47
Frankfurt am Main 34
London 32
Ho Chi Minh City 28
Ottawa 28
São Paulo 28
Dakar 27
Istanbul 26
Redondo Beach 26
Rome 26
Buffalo 24
Casablanca 24
San Diego 24
Des Moines 23
Dong Ket 23
Lagos 22
Hefei 21
Hyderabad 19
Kocaeli 17
Tokyo 17
Redwood City 16
Seoul 16
Turku 16
Hanoi 15
Lucca 15
New Delhi 14
Tashkent 14
Nanjing 13
Brussels 12
San Francisco 12
Guangzhou 11
Kent 11
Rio de Janeiro 11
Boulder 10
Fuzhou 10
Izmir 10
Brooklyn 9
Lancaster 9
Nuremberg 9
Phoenix 9
Baghdad 8
Belo Horizonte 8
Chicago 8
Genoa 8
Jacksonville 8
Norwalk 8
Ogden 8
Ankara 7
Bremen 7
Livorno 7
Mexico City 7
Montreal 7
Toronto 7
Vicopisano 7
Atlanta 6
Carrara 6
Council Bluffs 6
Denver 6
Düsseldorf 6
Guayaquil 6
Johannesburg 6
Marseille 6
Nairobi 6
Quanzhou 6
San Giuliano Terme 6
Shenzhen 6
Warsaw 6
Curitiba 5
Dearborn 5
Dhaka 5
Hebei 5
Pietrasanta 5
Totale 5.875
Nome #
Tissue thyroid hormones and thyronamines 269
Clinical profile of juvenile primary hyperparathyroidism: a prospective study 206
Assay of endogenous 3,5-diiodo-L-thyronine (3,5-T2) and 3,3’-diiodo-L-thyronine (3,3’-T2) in human serum: a feasibility study 197
A proteomic approach to study parathyroid glands 186
Evaluation of formalin-fixed paraffin-embedded tissues in the proteomic analysis of parathyroid glands. 182
Cinacalcet efficacy in patients with moderately severe primary hyperparathyroidism according to the European Medicine Agency prescription labeling. 180
Beta-catenin activation is not involved in sporadic parathyroid carcinomas and adenomas 179
ACE2 in the era of SARS-CoV-2: controversies and novel perspectives 171
Is There a Crucial Link Between Vitamin D Status and Inflammatory Response in Patients With COVID-19? 168
Hypovitaminosis D in patients with heart failure: effects on functional capacity and patients' survival 163
Parathyroid Hormone (PTH)-Related Peptides Family: An Intriguing Role in the Central Nervous System 162
Loss of p27 expression is associated with MEN1 gene mutations in sporadic parathyroid adenomas 157
Whole exome sequencing in familial isolated primary hyperparathyroidism 152
Come definire lo status della vitamina 25OHD: aspetti metodologici (laboratorio) e clinici (VDBP, free 25OHD, bioavailable 25(OH)D) 151
Clinical presentation and management of patients with primary hyperparathyroidism in Italy 150
Development of an algorithm to predict serum vitamin D levels using a simple questionnaire based on sunlight exposure 147
Exome analysis of a large family with Familial Isolated Primary Hyperparathyroidism (FIHP) and multiple cancers. 147
CDC73 mutational status and loss of parafibromin in the outcome of parathyroid cancer. 145
A Novel Mutation in the Calcium Sensing Receptor Gene in an Italian Family Affected by Autosomal Dominant Hypocalcemia 144
Epidemiology, pathogenesis of primary hyperparathyroidism: Current data 143
Risk factors for renal calcifications and determinants of hypercalciuria in patients with chronic, post-surgical hypoparathyroidism 143
Familial hypocalciuric hypercalcemia associated with a novel homozygous loss-of-function mutation, E671D, of the calcium-sensing receptor gene 140
Mutational and large deletion study of genes implicated in hereditary forms of primary hyperparathyroidism and correlation with clinical features 139
Development and primary characterization of a human thyroid organoid in vitro model for thyroid metabolism investigation 138
Correction to: Whole exome sequencing in familial isolated primary hyperparathyroidism 137
SAT-393 Cognitive Function Evaluation in an Italian Cohort of Patients with Post-Operative Hypoparathyroidism 137
Non-surgical management of primary hyperparathyroidism 135
Vitamin D status and cardiovascular outcome 129
Hypercalciuria: its value as a predictive risk factor for nephrolithiasis in asymptomatic primary hyperparathyroidism? 128
Aryl hydrocarbon receptor interacting protein (AIP) mutations occur rarely in sporadic parathyroid adenomas. 127
Do Patients with Atypical Parathyroid Adenoma Need Close Follow-up? 127
Selective Thyroid Hormone Receptor-Beta (TRβ) Agonists: New Perspectives for the Treatment of Metabolic and Neurodegenerative Disorders 123
OR07-05 Is Urinary Calcium the Only Predictor of Nephrolithiasis in Patients with Asymptomatic Primary Hyperparathyroidism? 118
Cinacalcet in the management of primary hyperparathyroidism: Post marketing experience of an Italian multicentre group 113
The role of cannabinoids in bone metabolism: A new perspective for bone disorders 113
HPLC-MS-MS 25OHVITAMIND LEVELS ARE ASSOCIATED WITH PROGNOSIS MARKERS OF HEART FAILURE 111
European Expert Consensus on Practical Management of Specific Aspects of Parathyroid Disorders in Adults and in Pregnancy: Recommendations of the ESE Educational Program of Parathyroid Disorders 110
Large genomic deletions inactivate the MEN1 gene in Multiple Endocrine Neoplasia (MEN1) families 108
CLINICAL PRESENTATION AND MANAGEMENT OF PATIENTS WITH PRIMARY HYPERPARATHYROIDISM IN ITALY 108
Functional Characterization of Four Mutations of the Calcium Sensing Receptor Gene Identified in Patients with Familial Hypocalciuric Hypercalcemia Type 1 105
null 102
Performance in Behavioral Testing in an Animal Model of Post-Surgical Hypoparathyroidism 102
Familial and Hereditary Forms of Primary Hyperparathyroidism 101
Mutational Analysis of Beta-catenin Exon 3 in Benign and Malignant Parathyroid Tumors. 101
Novel thyroid hormones 101
HPLC-MS/MS method for simultaneous analysis of plasma 2-hydroxybutyrate and 2-hydroxyisobutyrate: Development and clinical significance 100
Editorial: Calcium Metabolism: Hormonal Crosstalk, Pathophysiology and Disease 99
Functional characterization of a CDKN1B mutation in a Sardinian kindred with multiple endocrine neoplasia type 4 (MEN4) 97
Renal complications and quality of life in postsurgical hypoparathyroidism: a case–control study 97
La gestione clinica dell’iperparatiroidismo primario lieve 96
Hypomagnesuria is associated with nephrolithiasis in patients with asymptomatic primary hyperparathyroidism 96
CDC73/HRPT2 mutations and parafibromin immunohistochemistry in a large series of sporadic parathyroid carcinomas and atypical adenomas 90
3-iodothyronamine (T1AM) is taken up and rapidly metabolized in neuronal cells 88
Pseudohypoparathyroidism: focus on cerebral and renal calcifications 85
Clinical presentation and management of primary hyperparathyroidism in Italy 84
A Prospective Study on Juvenile Primary Hyperparathyroidism Population. 83
Transthyretin stabilization: An emerging strategy for the treatment of alzheimer’s disease? 78
Iter diagnostico nel paziente con iperparatiroidismo primario recidivato dopo paratiroidectomia 74
null 73
Normocalcemic primary hyperparathyroidism: a survey in a small village of Southern Italy 73
T1AM/TAAR1 System Reduces Inflammatory Response and β-Amyloid Toxicity in Human Microglial HMC3 Cell Line 72
null 70
An update on vitamin d metabolism 70
Serum calcium levels are associated with cognitive function in hypoparathyroidism: a neuropsychological and biochemical study in an Italian cohort of patients with chronic post-surgical hypoparathyroidism 70
Primary hyperparathyroidism due to atypical adenoma: clinical, biochemical and histological features of an Italian cohort 66
Myokines and Microbiota: New Perspectives in the Endocrine Muscle-Gut Axis 65
TH Metabolism and Active TH Metabolites in the Heart 65
Vitamin D measurement and effect on outcome in a cohort of patients with heart failure 64
Italian Guidelines for the Management of Sporadic Primary Hyperparathyroidism 63
Rare Causes of Hypercalcemia 51
Novel Thyroid Hormone Receptor-β Agonist TG68 Exerts Anti-Inflammatory, Lipid-Lowering and Anxiolytic Effects in a High-Fat Diet (HFD) Mouse Model of Obesity 45
Unmet therapeutic, educational and scientific needs in parathyroid disorders: Consensus statement from the first European Society of Endocrinology Workshop (PARAT) 45
Intact fibroblast growth factor 23 in heart failure with reduced and mildly reduced ejection fraction 43
Totale 8.497
Categoria #
all - tutte 26.065
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 26.065


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021370 0 0 0 0 52 24 7 48 54 73 51 61
2021/2022691 9 22 12 29 140 86 20 37 61 24 85 166
2022/20231.134 136 163 107 57 120 135 13 80 209 3 73 38
2023/2024662 68 66 85 52 71 96 56 17 1 4 53 93
2024/20252.319 19 73 68 115 235 259 168 134 221 279 240 508
2025/20261.682 255 413 493 364 157 0 0 0 0 0 0 0
Totale 8.497